Clinical NGS kit for Hematological Malignancies & analysis SW
HEMEaccuTest™ is intended for molecular genetic test of multiple genes related hematologic malignancy.
Diagnosis through qualitative analysis of hematologic malignancy
Purpose to assist in appropriate classification and prediction of prognosis
Working Process
Specification
| HEMEaccuTest™ | ||
|---|---|---|
| DNA | RNA | |
| Certification | CE-IVD | RUO |
| Target disease | Acute myeloid leukemia, acute lymphoid leukemia, myelodysplastic/myeloproliferative neoplasm, multiple myeloma, lymphoma | |
| Target Enrichment method | Hybridization & capture method | |
| Quantity | 96 test/kit (8 runs per kit, up to 12 samples per run) | |
| Specimen | Blood, bone marrow and lymph nodes | |
| Target gene | 108 genes | 53 genes(5 house-keeping genes) |
| Target size | 305 kb | 129 kb |
| Probes | 5′-biotinylated oligos (DNA based) | |
| Hands on time | 3 days | 3.5 days |
| Variants type | SNV, In, Del | Fusion |
| NGS platform & reagent kit | illumina MiSeq, MiSeq Dx / MiSeq Reagent kit, v3, 300cycles | |
| Analysis solution | NGeneAnalySys™ (CE) | |
Ordering information
| Products | Cat.no | Quantity | |
|---|---|---|---|
| RUO | CE-IVD | ||
| HEMEaccuTest™ DNA & NGeneAnalySys™ | NGB121R-096 |
NGB121V-096 |
96 tests |
NGB121R-048 |
NGB121V-048 |
48 tests |
|
| HEMEaccuTest™ RNA & NGeneAnalySys™ | NGB112R-012 |
On the Process |
12 tests |
NGB122R-048 |
48 tests |
||
